Efficacy and safety of novel and repurposed drugs for the treatment of drug-resistant tuberculosis
Background: There is widespread concern about the rise of drug-resistant TB because treatment outcomes of affected patients remain poor and treatment options are limited. After more than a forty-year gap without any breakthrough discovery, several new (bedaquiline and delamanid) and repurposed drugs...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Doctoral Thesis |
| Language: | English |
| Published: |
Faculty of Health Sciences
2020
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/11427/32322 |